Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 Biomarker group BEFREE "Ever smoking" was associated with elevated serum carcinoembryonic antigen, American Joint Committee on Cancer T category, metastasis, and poorer OS and RFS in patients with CRC (OS: hazard ratio [HR] = 1.74, 95% confidence interval [CI], 1.07-2.81, p = 0.025; RFS: HR = 1.66, 95% CI: 1.18-2.34, p = 0.004). 30076725 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 GeneticVariation group BEFREE "Triple hit" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements. 30043475 2018
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.100 Biomarker group BEFREE %p2PSA and PHI had the highest area under the receiver operating characteristic curve (AUC) of 0.723 and 0.772 (both p < 0.001), respectively, predicting cancer detection at biopsy than other predictors (tPSA, fPSA, %fPSA, and PSA density (AUC: 0.544, 0.538, 0.593, and 0.664, respectively). 29779925 2019
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100 GeneticVariation group BEFREE <b> Khan and colleagues demonstrate how serial blood-based liquid biopsies integrated with imaging and mathematical modeling can accurately "forecast" the time to treatment failure in patients with metastatic colorectal cancer treated with EGFR blockade, by early detection of molecular alterations associated with drug resistance in cell-free DNA.<i>Cancer Discov; 8(10); 1213-5. 30279194 2018
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.100 Biomarker group BEFREE <b> Kim and colleagues identify necrotic debris as a macropinocytic cargo in PTEN-deficient prostate cancer cells, which is catabolized to generate the nutrients and biomass necessary to support tumor cell growth and metabolism in nutrient-limiting conditions.<i>Cancer Discov; 8(7); 800-2. 29967075 2018
Entrez Id: 952
Gene Symbol: CD38
CD38
0.100 AlteredExpression group BEFREE <b> Overexpression of CD38 after PD-1/PD-L1 blockade increases extracellular adenosine levels and may contribute to acquired resistance to anti-PD-1/PD-L1 therapy.<i>Cancer Discov; 8(9); 1066-8. 30181171 2018
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 Biomarker group BEFREE <b> Overexpression of CD38 after PD-1/PD-L1 blockade increases extracellular adenosine levels and may contribute to acquired resistance to anti-PD-1/PD-L1 therapy.<i>Cancer Discov; 8(9); 1066-8. 30181171 2018
Entrez Id: 64123
Gene Symbol: ADGRL4
ADGRL4
0.020 Biomarker group BEFREE <b><i>Results</i>:</b> Clinicopathologic correlations and <i>in vivo</i> models indicated ELTD1 as a tumor suppressor gene, whereas <i>in vitro</i> experiments suggested that ELTD1 could promote malignancy in HCC cell lines. 30026838 2018
Entrez Id: 4233
Gene Symbol: MET
MET
0.100 Biomarker group BEFREE <b>:</b> c-MET pathway over-activation is the signature of malignancy acquisition or chemotherapy resistance of many cancers. 30646583 2019
Entrez Id: 7089
Gene Symbol: TLE2
TLE2
0.010 Biomarker group BEFREE <b>:</b> Anilin actin binding protein (ANLN) and transducing-like enhancer protein 2 (TLE2) are associated with cancer patient survival and progression. 31766561 2019
Entrez Id: 4059
Gene Symbol: BCAM
BCAM
0.040 Biomarker group BEFREE <b>Aim</b>: This review aims to compare the development, characteristics and validity of three widely used breast cancer screening belief tools (the Champion's Health Belief Model Scale [CHBMS], the Breast Module of a Cancer Awareness Measures [BCAM] and the Breast Cancer Screening Beliefs Questionnaire [BCSBQ]). 31298055 2019
Entrez Id: 64754
Gene Symbol: SMYD3
SMYD3
0.100 AlteredExpression group BEFREE <b>Aim:</b> SMYD3 enzyme is overexpressed in many types of cancer and its role in the methylation of cytoplasmic mitogen-activated protein kinase, kinase kinase 2 (MAP3K2), has been linked to promotion of Kras-driven cancer in pancreatic ductal and lung adenocarcinoma. 31280673 2019
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.100 Biomarker group BEFREE <b>Aim:</b> Simultaneous inhibition of MMP-2 and HDAC8 may be an effective strategy to target cancer. 31370697 2019
Entrez Id: 55869
Gene Symbol: HDAC8
HDAC8
0.100 Biomarker group BEFREE <b>Aim:</b> Simultaneous inhibition of MMP-2 and HDAC8 may be an effective strategy to target cancer. 31370697 2019
Entrez Id: 10746
Gene Symbol: MAP3K2
MAP3K2
0.060 PosttranslationalModification group BEFREE <b>Aim:</b> SMYD3 enzyme is overexpressed in many types of cancer and its role in the methylation of cytoplasmic mitogen-activated protein kinase, kinase kinase 2 (MAP3K2), has been linked to promotion of Kras-driven cancer in pancreatic ductal and lung adenocarcinoma. 31280673 2019
Entrez Id: 960
Gene Symbol: CD44
CD44
0.100 Biomarker group BEFREE <b>Aim:</b> There is no consensus regarding the clinical significance of CD44 and CD24 as cancer stem cell (CSC) marker in colorectal cancer (CRC). 30942083 2019
Entrez Id: 100133941
Gene Symbol: CD24
CD24
0.100 Biomarker group BEFREE <b>Aim:</b> There is no consensus regarding the clinical significance of CD44 and CD24 as cancer stem cell (CSC) marker in colorectal cancer (CRC). 30942083 2019
Entrez Id: 4810
Gene Symbol: NHS
NHS
0.100 Biomarker group BEFREE <b>Aim:</b> This study evaluated the patient experience of receiving subcutaneous chemotherapy at home via a unique 'Cancer Treatment at Home' outreach service adapted by the UK Clatterbridge Cancer Centre NHS Foundation Trust. 31441319 2019
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.100 AlteredExpression group BEFREE <b>Areas covered</b>: In this review, we have used The Cancer Genome Atlas (TCGA) database to explore the relationship between the expression of the major ABC proteins involved in cancer chemoresistance in the most common types of cancer, and the drugs used in the treatment of these tumors that are substrates of these pumps. 31185182 2019
Entrez Id: 5894
Gene Symbol: RAF1
RAF1
0.100 GeneticVariation group BEFREE <b>Areas covered</b>: This article covers the pertinent literature published on RAF kinase inhibitors from 2010 to 2018, as well as the potential use of these compounds as therapeutics for cancer. 31370713 2019
Entrez Id: 22882
Gene Symbol: ZHX2
ZHX2
0.100 GeneticVariation group BEFREE <b>Areas covered</b>: This article covers the pertinent literature published on RAF kinase inhibitors from 2010 to 2018, as well as the potential use of these compounds as therapeutics for cancer. 31370713 2019
Entrez Id: 56915
Gene Symbol: EXOSC5
EXOSC5
0.020 Biomarker group BEFREE <b>Background and Objective:</b> Exosome component 5 (EXOSC5) is a novel cancer-related gene that is aberrantly expressed in various malignances. 31380280 2019
Entrez Id: 11061
Gene Symbol: CNMD
CNMD
0.030 Biomarker group BEFREE <b>Background</b>: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). 28638739 2017
Entrez Id: 3664
Gene Symbol: IRF6
IRF6
0.040 Biomarker group BEFREE <b>Background/Aims:</b> The tumor-suppressive functions of interferon regulatory factor 6 (IRF6) in some tumors have been preliminarily established, but its pathogenesis and underlying molecular mechanisms in breast cancer, the most common malignancy in women, remains poorly understood. 31417306 2019
Entrez Id: 5591
Gene Symbol: PRKDC
PRKDC
0.100 Biomarker group BEFREE <b>Background:</b> DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is known to function in several types of cancer. 28819445 2017